Cutaneous Squamous Cell Carcinoma (CSCC)

DBCOND0168836NeoplasmsSkin and Subcutaneous Tissue Diseases

Cutaneous Squamous Cell Carcinoma (CSCC) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Squamous Cell Carcinoma of the Skin · Squamous Cell Carcinoma, Skin · Cutaneous Squamous Cell Carcinoma · Epidermoid Carcinoma · Squamous Cell Skin Carcinoma
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM000769240SNOMED CT1162767002MedDRA10007349UMLSC0007137

What you can answer from here — as of November 15, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
139Clinical trialsPhase, status and sponsor resolved per trial
Sign in
11Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Cutaneous Squamous Cell Carcinoma (CSCC) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In